Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Tyrosinase protects human melanocytes from ROS-generating compounds

Academic Article
Publication Date:
2003
abstract:
The effects of two tetrahydroisoquinolines (TlQs), tetrahydropapaveroline (THP) and salsolinol (SAL), on human primary melanocytes were studied. These compounds are naturally occurring alkaloids deriving from the condensation of dopamine with aldehydes. The effects on the viability were studied by treating the cells with variable concentration of THP or SAL; both TlQs were well tolerated up to roughly 30 muM. At higher concentrations, THP became overtly toxic while SAL showed no cytotoxic effect up to 100 muM TlQs treatment determined an impairment of intracellular activity of antioxidant enzymes, like SOD, DT-diaphorase, and glutathione peroxidase. A decrease of alpha-ketoglutarate dehydrogenase activity was also evidenced following TlQs treatment; a very strong diminution was found in THP-treated cells, whose viability was highly decreased. Both TlQs increased tyrosinase-specific mRNA transcription followed, in the case of SAL, by an activation of tyrosinase. In the presence of tyrosinase inhibitors TlQs treatment resulted in a sharp cytotoxic effect even at concentrations normally well tolerated. Taken together these data suggest that tyrosinase represents an outstanding protective mechanism against ROS-generating compounds, once primary detoxifying mechanisms are impaired or not available. (C) 2003 Elsevier Science (USA). All rights reserved.
Iris type:
01.01 Articolo in rivista
Keywords:
melanocyte; reactive oxygen species; salsolinol; tetrahydropapaveroline; tetrahydroisoquinoline; tyrosinase
List of contributors:
Foppoli, Cesira
Handle:
https://iris.cnr.it/handle/20.500.14243/275710
Published in:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (PRINT)
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)